As Global Pharmaceutical output continues to soar driven by new technologies drawn from the broader Healthcare space, we believe there is the need for a dedicated European Healthcare Boutique to help investors identify new opportunities and piece together the increasingly complex landscape.
Our ever expanding coverage includes the EU Pharma majors, Global CDMO’s and a set of carefully selected Biotech companies.
Intron Health aims to be investors’ Healthcare partner of choice with high quality thought leadership.
Our ever-expanding global coverage finds investment opportunities with structural growth that benefit from the R&D SuperCycle.
Founded by Naresh Chouhan and Dominic Rose in 2016, the team has more than 75 years of combined experience.
We’ve Entered an R&D SuperCycle
Combined Peak Sales of Approved Drugs from Large Caps by Year
Big Pharma Phase 3 Success Rates by Year